Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 39 results.
User Information
Export Records
  1. 1.   Beyond traditional screening: Unveiling antibiotic potentials of actinomycetes in extreme environments
  2. Trenozhnikova, Lyudmila P; Baimakhanova, Gul B; Baimakhanova, Baiken B; Balgimbayeva, Assya S; Daugaliyeva, Saule T; Faizulina, Elmira R; Tatarkina, Larisa G; Spankulova, Gulzhan A; Berillo, Dmitriy A; Beutler,John
  3. Heliyon. 2024, Nov 30; 10(22): e40371.
  1. 2.   Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome
  2. Cern, Ahuva; Skoczen,Sarah; Snapp, Kelsie S; Hod, Atara; Zilbersheid, Daniel; Bavli, Yaelle; Alon-Maimon, Tamar; Bachrach, Gilad; Wei, Xiaohui; Berman, Bella; Yassour, Moran; Cedrone,Edward; Neun,Barry; Dobrovolskaia,Marina; Clogston,Jeffrey; Stern,Steve; Barenholz, Yechezkel
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2024, Aug 2; 373: 713-726.
  1. 3.   Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extract Library
  2. Martínez-Fructuoso, Lucero; Arends, S J Ryan; Freire,Vitor; Evans,Jason; DeVries, Sean; Peyser,Brian; Akee,Rhone; Thornburg,Chris; Kumar,Rohitesh; Ensel,Susan; Morgan, Gina M; McConachie, Grant D; Veeder, Nathan; Duncan, Leonard R; Grkovic,Tanja; O'Keefe,Barry
  3. ACS Infectious Diseases. 2023, May 10;
  1. 4.   Structure of Helicobacter pylori dihydroneopterin aldolase suggests a fragment-based strategy for isozyme-specific inhibitor design
  2. Shaw,Gary; Fan,Lixin; Cherry,Scott; Shi,Genbin; Tropea, Joseph E; Ji,Xinhua
  3. Current Research in Structural Biology. 2023, Jan 30; 5: 100095.
  1. 5.   The effect of modulation of gut microbiome profile on radiation-induced carcinogenesis and survival
  2. Cook, John A; Sowers, Anastasia L; Choudhuri, Rajani; Gadisetti, Chandramouli; Edmondson,Elijah; Gohain, Sangeeta; Krishna, Murali C; Mitchell, James B
  3. Journal of Radiation Research. 2022, Oct 17;
  1. 6.   Novel Opportunity to Reverse Antibiotic Resistance: To Explore Traditional Chinese Medicine With Potential Activity Against Antibiotics-Resistance Bacteria
  2. Su, Ting; Qiu, Ye; Hua, Xuesi; Ye, Bi; Luo, Haoming; Liu, Da; Qu, Peng; Qiu, Zhidong
  3. Frontiers in microbiology. 2020, DEC 22; 11
  1. 7.   NusG-Dependent RNA Polymerase Pausing and Tylosin-Dependent Ribosome Stalling Are Required for Tylosin Resistance by Inducing 23S rRNA Methylation in Bacillus subtilis
  2. Yakhnin, Helen; Yakhnin, Alexander V; Mouery, Brandon L; Mandell, Zachary F; Karbasiafshar, Catherine; Kashlev,Mikhail; Babitzke, Paul
  3. mBio. 2019, Nov; 10(6): pii: e02665-19..
  1. 8.   Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults A Systematic Review and Meta-analysis
  2. Pepper, Dominique J.; Sun, Junfeng; Rhee, Chanu; Welsh, Judith; Powers,John; Danner, Robert L.; Kadri, Sameer S.
  3. Chest. 2019, JUN; 155(6): 1109-1118.
  1. 9.   Inhibition of Bacterial Gene Transcription with an RpoN-Based Stapled Peptide
  2. Payne, Sterling R; Pau, Daniel I; Whiting, Amanda L; Kim, Ye Joon; Pharoah, Blaze M; Moi, Christina; Boddy, Christopher N; Bernal, Federico
  3. Cell Chemical Biology. 2018, Sep 20; 25(9): 1059-1066.e4.
  1. 10.   A close look onto structural models and primary ligands of metallo-beta-plactamases
  2. Raczynska, Joanna E.; Shabalin, Ivan G.; Minor, Wladek; Wlodawer,Alexander; Jaskolski, Mariusz
  3. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 2018, Sep; 40: 1-12.
  1. 11.   Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
  2. Namasivayam, Sivaranjani; Maiga, Mamoudou; Yuan, Wuxing; Thovarai, Vishal; Costa, Diego L; Mittereder, Lara R; Wipperman, Matthew F; Glickman, Michael S; Dzutsev, Amiran; Trinchieri, Giorgio; Sher, Alan
  3. Microbiome. 2017, Jul 07; 5(1): 71.
  1. 12.   Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers
  2. Howard, James J.; Sturge, Carolyn R.; Moustafa, Dina A.; Daly, Seth M.; Batty, Kimberly; Felder, Christina F.; Zamora, Danniel; Yabe-Gill, Marium; Labandeira-Rey, Maria; Bailey, Stacey M.; Wong, Michael; Goldberg, Joanna B.; Geller, Bruce L.; Greenberg, David E.
  3. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2017, Apr; 61(4):
  1. 13.   Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties
  2. Shi, G. B.; Shaw, G.; Liang, Y. H.; Subburaman, P.; Li, Y.; Wu, Y.; Yan, H. G.; Ji, X. H.
  3. Bioorganic & Medicinal Chemistry. 2012, Jan; 20(1): 47-57.
  1. 14.   Synergistic Interaction of the Triple Combination of Amphotericin B, Ciprofloxacin, and Polymorphonuclear Neutrophils against Aspergillus fumigatus
  2. Stergiopoulou, T.; Meletiadis, J.; Sein, T.; Papaioannidou, P.; Walsh, T. J.; Roilides, E.
  3. Antimicrobial Agents and Chemotherapy. 2011, Dec; 55(12): 5923-5929.
  1. 15.   Synthesis and Anticancer Activity of 13-Membered Cyclic Enediynes
  2. Sharma, M.; Joshi, M. C.; Kumar, V.; Malhotra, S. V.; Rawat, D. S.
  3. Archiv Der Pharmazie. 2011, Sep; 344(9): 564-571.
  1. 16.   Synthesis and Biological Evaluation of ABCD Ring Fragments of the Kibdelones
  2. Sloman, D. L.; Mitasev, B.; Scully, S. S.; Beutler, J. A.; Porco, J. A.
  3. Angewandte Chemie-International Edition. 2011, Mar 7; 50(11): 2511-2515.
  1. 17.   Substituted E-3-(3-Indolylmethylene)-1,3-dihydroindo1-2-ones with Antitumor Activity. In Depth Study of the Effect on Growth of Breast Cancer Cells
  2. Andreani, A.; Bellini, S.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Calonghi, N.; Cappadone, C.; Zini, M.; Stefanelli, C.; Masotti, L.; Shoemaker, R. H.
  3. Journal of Medicinal Chemistry. 2010, Aug; 53(15): 5567-5575.
  1. 18.   Natural product scaffolds as leads-to drugs
  2. Newman, D. J.; Cragg, G. M.
  3. Future Medicinal Chemistry. 2009, Nov; 1(8): 1415-1427.
  1. 19.   ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC
  2. Stockwin, L. H.; Yu, S. X.; Stotler, H.; Hollingshead, M. G.; Newton, D. L.
  3. Bmc Cancer. 2009 9(63): 1-13.
  1. 20.   Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H
  2. March, C.; Beutler, J. A.; Wamiru, A.; Budihas, S.; Mollmann, U.; Heinisch, L.; Mellors, J. W.; Le Grice, S. F.; Pommier, Y.
  3. Antimicrobial Agents and Chemotherapy. 2008 52(1): 361-364.
  1. 21.   Crystal structures of human alpha-defensins HNP4, HD5, and HD6
  2. Szyk, A.; Wu, Z. B.; Tucker, K.; Yang, D.; Lu, W. Y.; Lubkowski, J.
  3. Protein Science. 2006, Dec; 15(12): 2749-2760.
  1. 22.   Human beta-defensins
  2. Pazgier, M.; Hoover, D. M.; Yang, D.; Lu, W.; Lubkowski, J.
  3. Cellular and Molecular Life Sciences. 2006, Jun; 63(11): 1294-1313.
  1. 23.   Broad spectrum antimicrobial activity of leukocyte extracts from the American alligator (Alligator mississipiensis)
  2. Merchant, M. E.; Leger, N.; Jerkins, E.; Mills, K.; Pallansch, M. B.; Paulman, R. L.; Ptak, R. G.
  3. Veterinary Immunology and Immunopathology. 2006, Apr; 110(3-4): 221-228.
  1. 24.   International collaboration in drug discovery and development from natural sources
  2. Cragg, G. M.; Newman, D. J.
  3. Pure and Applied Chemistry. 2005, NOV; 77(11): 1923-1942.
  1. 25.   Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant
  2. Kurosaka, K.; Chen, Q.; Yarovinsky, F.; Oppenheim, J. J.; Yang, D.
  3. Journal of Immunology. 2005, MAY 15; 174(10): 6257-6265.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel